跳至主要内容
临床试验/TCTR20240320002
TCTR20240320002已完成1 期

Efficacy and complications of full dose versus half dose of botulinum toxin type A injection in Benign Essential Blepharospasm

The Faculty of Medicine, Thammasat University0 个研究点目标入组 20 人开始时间: 2024年3月20日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

There were no significant differences between groups receiving half-dose and full-dose BTX-A injections in the latency to response (5.80 plus or minus 1.99 versus 6.80 plus or minus 1.93, p value equal 0.214), self-response scale (2.70 plus or minus 0.48 versus 2.20 plus or minus 0.63, p value equal 0.067), and patient satisfaction scale (8.10 plus or minus 1.60 versus 8.30 plus or minus 1.49, p value equal 0.776) at 12 weeks.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • The study enrolled patients diagnosed with BEB by either a neuro-ophthalmologist or neurologist who had received the most recent BTX-A injection for over three months.

排除标准

  • Exclusion criteria encompassed individuals with a documented allergic response to BTX-A and patients displaying other craniofacial dyskinesia conditions such as apraxia of lid opening or facial synkinesis.

研究者

发起方
The Faculty of Medicine, Thammasat University

相似试验